References
- Hao J, Li Y, Zhang X, et al. The prevalence and mortality of hyponatremia is seriously underestimated in Chinese general medical patients: an observational retrospective study. BMC Nephrol. 2017;18(1):328.
- Wald R, Jaber BL, Price LL, et al. Impact of hospital-associated hyponatremia on selected outcomes. Arch Intern Med. 2010;170(3):294–302.
- Sturdik I, Adamcova M, Kollerova J, et al. Hyponatraemia is an independent predictor of in-hospital mortality. Eur J Intern Med. 2014;25(4):379–382.
- Golestaneh L, Neugarten J, Kaskel F, et al. Progressive kidney disease may not alter the association of hyponatremia with mortality. Clin Exp Nephrol. 2018;22(4):889–897.
- Mehran R, Nikolsky E. Contrast-induced nephropathy: definition, epidemiology, and patients at risk. Kidney Int Suppl. 2006;100:11–15.
- Rear R, Bell RM, Hausenloy DJ. Contrast-induced nephropathy following angiography and cardiac interventions. Heart. 2016;102(8):638–648.
- Nash K, Hafeez A, Hou S. Hospital-acquired renal insufficiency. Am J Kidney Dis. 2002;39(5):930–936.
- Lee WC, Fang HY, Fang CY. Tolvaptan rescue contrast-induced acute kidney injury: a case report. Medicine (Baltimore)). 2018;97(17):e0570–19.
- Arroyo V, Rodés J, Gutiérrez-Lizárraga MA, et al. Prognostic value of spontaneous hyponatremia in cirrhosis with ascites. Am J Dig Dis. 1976;21(3):249–256.
- Sica DA. Hyponatremia and heart failure-pathophysiology and implications. Congest Heart Fail. 2005;11(5):274–277.
- Spasovski G, Vanholder R, Allolio B, et al. Clinical practice guideline on diagnosis and treatment of hyponatraemia. Eur J Endocrinol. 2014;170:1–47.
- Thomsen HS, Morcos SK. Contrast media and the kidney: European Society of Urogenital Radiology (ESUR) guidelines. Br J Radiol. 2003;76(908):513–518.
- Stevens LA, Claybon MA, Schmid CH, et al. Evaluation of the Chronic Kidney Disease Epidemiology Collaboration equation for estimating the glomerular filtration rate in multiple ethnicities. Kidney Int. 2011;79(5):555–562.
- Hoorn EJ, Zietse R. Hyponatremia and mortality: moving beyond associations. Am J Kidney Dis. 2013;62(1):139–149.
- Huang H, Jolly SE, Airy M, et al. Associations of dysnatremias with mortality in chronic kidney disease. Nephrol Dial Transplant. 2017;32:1204–1210.
- Swart RM, Hoorn EJ, Betjes MG, et al. Hyponatremia and inflammation: the emerging role of interleukin-6 in osmoregulation. Nephron Physiol. 2011;118(2):45–51.
- Yin WJ, Yi YH, Guan XF, et al. Preprocedural prediction model for contrast-induced nephropathy patients. J Am Heart Assoc. 2017;6:1–11.
- Toso A, Leoncini M, Maioli M, et al. Relationship between inflammation and benefits of early high-dose rosuvastatin on contrast-induced nephropathy in patients with acute coronary syndrome: the pathophysiological link in the PRATO-ACS study (Protective Effect of Rosuvastatin and Antiplatelet Therapy on Contrast-Induced Nephropathy and Myocardial Damage in Patients With Acute Coronary Syndrome Undergoing Coronary Intervention). JACC Cardiovasc Interv. 2014;7(12):1421–1429.
- Adrogué HJ. Hyponatremia in heart failure. Methodist Debakey Cardiovasc J. 2017;13(1):40.
- Sirken G, Raja R, Garces J, et al. Contrast-induced translocational hyponatremia and hyperkalemia in advanced kidney disease. Am J Kidney Dis. 2004;44:1127.